Associated Papers
Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y et al.
International Journal of Hematology, 2019
CCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signaling.
Starokadomskyy P et al.
The Journal of Clinical Investigation, 2013
Select a paper to view details